SABBY 13G COCP 5.12.21

Company

Cocrystal Pharma, Inc.

Filed

May 12, 2021

Accession Number

0001535610-21-000090

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →